ArticleRespirology case reports2026
A Rare Case of Anti-Yo Antibody Positive Paraneoplastic Neurologic Syndromes With EGFR Mutation Positive Non-Small Cell Lung Cancer.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Case of Anti-Yo Antibody Positive Paraneoplastic Neurologic Syndromes With EGFR Mutation Positive Non-Small Cell Lung Cancer.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paraneoplastic neurologic syndromes (PNS) associated with anti-Yo antibody typically occur in females with ovarian or breast cancer, and their occurrence in lung cancer is rare. We report the first case of anti-Yo antibody positive PNS in a patient with EGFR mutation-positive non-small cell lung cancer (NSCLC). A 74-year-old male presented with acute vertigo and progressive cerebellar ataxia. Anti-Yo antibody was positive, and transbronchial biopsy confirmed papillary adenocarcinoma with EGFR exon 21 L858R mutation. Brain MRI also revealed multiple metastases, and cerebrospinal fluid cytology was positive for malignant cells. Despite the presence of brain metastases and leptomeningeal metastasis, neurological symptoms were attributed primarily to anti-Yo PNS based on clinical presentation. Chemotherapy was discontinued due to interstitial lung disease, but subsequent steroid therapy resulted in modest improvement of ataxic symptoms. This case suggests that NSCLC presenting with anti-Yo PNS may harbour EGFR mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.